SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-18-001309
Filing Date
2018-05-15
Accepted
2018-05-14 18:43:35
Documents
4
Period of Report
2018-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k-0518.htm 8-K 22548
2 FOURTH ADDENDUM TO ASSET PURCHASE AGREEMENT pharmacyte_ex1001.htm EX-10.1 25898
3 THIRD AMENDMENT TO LICENSING AGREEMENT pharmacyte_ex1002.htm EX-10.2 21740
4 SECOND AMENDMENT TO LICENSING AGREEMENT pharmacyte_ex1003.htm EX-10.3 25796
  Complete submission text file 0001683168-18-001309.txt   97315
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 18832498
SIC: 2833 Medicinal Chemicals & Botanical Products